{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:58Z","timestamp":1790371078021,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.gtc.2020.01.008","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T18:24:00Z","timestamp":1588875840000},"page":"331-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Epstein-Barr Virus and Cytomegalovirus Infections of the Liver"],"prefix":"10.1016","volume":"49","author":[{"given":"Chalermrat","family":"Bunchorntavakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gtc.2020.01.008_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2020.01.008_bib2","article-title":"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults","author":"Friel","year":"2019"},{"key":"10.1016\/j.gtc.2020.01.008_bib3","article-title":"Clinical manifestations and treatment of Epstein-Barr virus infection","author":"Sullivan","year":"2019"},{"issue":"33","key":"10.1016\/j.gtc.2020.01.008_bib4","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.3748\/wjg.v16.i33.4130","article-title":"Epstein-Barr virus: silent companion or causative agent of chronic liver disease?","volume":"16","author":"Petrova","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2020.01.008_bib5","doi-asserted-by":"crossref","first-page":"6156581","DOI":"10.1155\/2019\/6156581","article-title":"A\u00a0Practical Review of Cytomegalovirus in Gastroenterology and Hepatology","volume":"2019","author":"Fakhreddine","year":"2019","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"10.1016\/j.gtc.2020.01.008_bib6","first-page":"446","article-title":"Hepatitis caused by herpes viruses: a review","volume":"19","author":"Noor","year":"2018","journal-title":"J\u00a0Dig Dis"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/00365521.2015.1121516","article-title":"A\u00a0prospective study on the causes of notably raised alanine aminotransferase (ALT)","volume":"51","author":"Bjornsson","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2036.2012.05122.x","article-title":"Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis","volume":"36","author":"Vine","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12664-015-0613-0","article-title":"Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults","volume":"34","author":"Gupta","year":"2015","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2018.12.010","article-title":"Hepatic manifestations of lymphoproliferative disorders","volume":"23","author":"Bunchorntavakul","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2020.01.008_bib12","article-title":"Virology of Epstein-Barr virus","author":"Sulivan","year":"2019"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/oxfordjournals.aje.a121369","article-title":"Infectious mononucleosis in a general population","volume":"95","author":"Heath","year":"1972","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.gtc.2020.01.008_bib14","article-title":"Infectious mononucleosis","author":"Aronson","year":"2019"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/infdis\/132.5.546","article-title":"A\u00a0prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody","volume":"132","author":"Evans","year":"1975","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/01.smj.0000216469.04854.2a","article-title":"Epstein Barr virus hepatitis: case series and review","volume":"99","author":"Crum","year":"2006","journal-title":"South Med J"},{"issue":"8","key":"10.1016\/j.gtc.2020.01.008_bib17","first-page":"1314","article-title":"Mild infectious mononucleosis presenting with transient mixed liver disease: case report with a literature review","volume":"53","author":"Lawee","year":"2007","journal-title":"Can Fam Physician"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1022592801060","article-title":"Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult","volume":"48","author":"Hinedi","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2020.01.008_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202213","article-title":"Epstein-Barr virus-associated cholestatic hepatitis","volume":"2013","author":"Salva","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.gtc.2020.01.008_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/00365521.2017.1319972","article-title":"Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes","volume":"52","author":"Leonardsson","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/lt.500040612","article-title":"Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature","volume":"4","author":"Feranchak","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/0016-5085(87)90246-0","article-title":"Hepatitis in fatal infectious mononucleosis","volume":"93","author":"Markin","year":"1987","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0168-8278(95)80015-8","article-title":"Fulminant hepatitis due to Epstein-Barr virus infection","volume":"23","author":"Papatheodoridis","year":"1995","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1572-0241.1999.00806.x","article-title":"Ascites and severe hepatitis complicating Epstein-Barr infection","volume":"94","author":"Devereaux","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2020.01.008_bib25","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s10620-014-3029-2","article-title":"Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group","volume":"59","author":"Mellinger","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jmv.23489","article-title":"Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: report of two cases","volume":"85","author":"Gupta","year":"2013","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/ijmm.IJMM_17_378","article-title":"Acute hepatitis due to Epstein-Barr virus with cross-reacting antibodies to cytomegalovirus","volume":"36","author":"Karadeniz","year":"2018","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2009.05.022","article-title":"Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E","volume":"45","author":"Fogeda","year":"2009","journal-title":"J\u00a0Clin Virol"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3851\/IMP2991","article-title":"Acute viral hepatitis presenting as cytomegalovirus, hepatitis E and Epstein-Barr virus IgM antibody positive","volume":"21","author":"Huang","year":"2016","journal-title":"Antivir Ther"},{"issue":"12","key":"10.1016\/j.gtc.2020.01.008_bib30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/MEG.0b013e32832f5be4","article-title":"Acute hepatitis E infection associated with a false-positive serology against Epstein-Barr virus","volume":"21","author":"Ghinoiu","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jmv.23827","article-title":"Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection","volume":"86","author":"Hyams","year":"2014","journal-title":"J\u00a0Med Virol"},{"issue":"10","key":"10.1016\/j.gtc.2020.01.008_bib32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.5858\/arpa.2018-0208-RA","article-title":"Epstein-barr virus hepatitis: a review of clinicopathologic features and differential diagnosis","volume":"142","author":"Schechter","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"580","key":"10.1016\/j.gtc.2020.01.008_bib33","first-page":"56","article-title":"Death from massive hepatic necrosis in infectious mononucleosis","volume":"85","author":"Adkins","year":"1977","journal-title":"N\u00a0Z Med J"},{"issue":"9","key":"10.1016\/j.gtc.2020.01.008_bib34","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0b013e31802ffdd5","article-title":"Epstein-Barr virus hepatitis: diagnostic value of in\u00a0situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients","volume":"31","author":"Suh","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gtc.2020.01.008_bib35","first-page":"185","article-title":"Fatal infectious mononucleosis. Association with liver necrosis and herpes-like virus particles","volume":"99","author":"Chang","year":"1975","journal-title":"Arch Pathol"},{"issue":"7","key":"10.1016\/j.gtc.2020.01.008_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1053\/hupa.2001.25597","article-title":"Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes","volume":"32","author":"Kimura","year":"2001","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.gtc.2020.01.008_bib37","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1440-1746.2006.03257.x","article-title":"Ganciclovir and the treatment of Epstein-Barr virus hepatitis","volume":"21","author":"Adams","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jmv.23766","article-title":"Unusual presentation of Epstein-Barr virus hepatitis treated successfully with valganciclovir","volume":"86","author":"Cauldwell","year":"2014","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s15010-012-0303-0","article-title":"Severe EBV hepatitis treated with valganciclovir","volume":"41","author":"Pisapia","year":"2013","journal-title":"Infection"},{"issue":"8975","key":"10.1016\/j.gtc.2020.01.008_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1665-2681(19)31398-5","article-title":"Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact?","volume":"12","author":"Zellos","year":"2013","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.gtc.2020.01.008_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229615","article-title":"Autoimmune hepatitis following Epstein-Barr virus infection: a diagnostic dilemma","volume":"12","author":"Peng","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-200402000-00017","article-title":"Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis","volume":"16","author":"Chiba","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12328-013-0438-2","article-title":"Possible autoimmune hepatitis induced after chronic active Epstein-Barr virus infection","volume":"7","author":"Wada","year":"2014","journal-title":"Clin J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2020.01.008_bib45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/0961203314527367","article-title":"Chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis exacerbation in a patient with systemic lupus erythematosus","volume":"23","author":"Yamashita","year":"2014","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.gtc.2020.01.008_bib46","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2169\/internalmedicine.31.1190","article-title":"Chronic active Epstein-Barr virus infection in an adult","volume":"31","author":"Sakamoto","year":"1992","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.inf.0000105182.51471.4b","article-title":"Persistent hepatitis associated with chronic active Epstein-Barr virus infection","volume":"23","author":"Yuge","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib48","article-title":"Infectious mononucleosis (Epstein-Barr virus infection) and chronic hepatitis","volume":"16","author":"Calkic","year":"2019","journal-title":"Med Glas (Zenica)"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004836-198906000-00021","article-title":"Chronic Epstein-Barr virus infection: a cause of granulomatous hepatitis?","volume":"11","author":"Biest","year":"1989","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1023\/A:1005434015863","article-title":"Vanishing bile duct syndrome associated with chronic EBV infection","volume":"45","author":"Kikuchi","year":"2000","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/dth.12271","article-title":"Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis","volume":"28","author":"Cetkovska","year":"2015","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12525","article-title":"Hepatitis due to EBV-reactivation under infliximab in a psoriasis patient","volume":"30","author":"Sondermann","year":"2017","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jhep.2006.02.006","article-title":"The role of Epstein-Barr virus in acute and chronic hepatitis","volume":"44","author":"Drebber","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib54","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2006.03.002","article-title":"The paradox of Epstein-Barr virus-associated hepatitis","volume":"44","author":"Negro","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12879-018-3488-8","article-title":"Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure","volume":"18","author":"Hu","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.prp.2018.10.037","article-title":"EBV as a potential risk factor for hepatobiliary system cancer: a meta-analysis with 918 cases","volume":"215","author":"Chen","year":"2019","journal-title":"Pathol Res Pract"},{"issue":"9","key":"10.1016\/j.gtc.2020.01.008_bib57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/003655200750023075","article-title":"Detection of Epstein-Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C-positive patients","volume":"35","author":"Sugawara","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/viro.1999.9619","article-title":"Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression","volume":"256","author":"Sugawara","year":"1999","journal-title":"Virology"},{"issue":"23","key":"10.1016\/j.gtc.2020.01.008_bib59","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.3748\/wjg.v10.i23.3409","article-title":"Epstein-Barr virus in hepatocellular carcinogenesis","volume":"10","author":"Li","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3835(02)00695-X","article-title":"Epstein-Barr virus and human hepatocellular carcinoma","volume":"192","author":"Akhter","year":"2003","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"issue":"5 Pt 1","key":"10.1016\/j.gtc.2020.01.008_bib62","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib63","first-page":"248","article-title":"Post-transplantation lymphoproliferative disorder with gastrointestinal involvement","volume":"31","author":"Inayat","year":"2018","journal-title":"Ann Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2020.01.008_bib64","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder","volume":"15","author":"Luskin","year":"2015","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.gtc.2020.01.008_bib65","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/TP.0000000000002146","article-title":"The changing epidemiology of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients over 30 years: a single-center experience","volume":"102","author":"Peters","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jclinpath-2012-201139","article-title":"Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study","volume":"66","author":"Lo","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib67","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/TXD.0000000000000557","article-title":"Epstein-barr virus-positive posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis, clinical manifestations, diagnosis, and management","volume":"2","author":"Nijland","year":"2016","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOT.0b013e3283465715","article-title":"Posttransplant lymphoproliferative disease following liver transplantation","volume":"16","author":"Kamdar","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"issue":"9","key":"10.1016\/j.gtc.2020.01.008_bib69","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, EBV infection and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.gtc.2020.01.008_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/v10080444","article-title":"Molecular determinants and the regulation of human cytomegalovirus Latency and Reactivation","volume":"10","author":"Collins-McMillen","year":"2018","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.gtc.2020.01.008_bib73","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.gtc.2020.01.008_bib74","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/jir722","article-title":"Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission","volume":"205","author":"Stowell","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.gtc.2020.01.008_bib76","first-page":"227","article-title":"Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults","volume":"152","author":"Bonnet","year":"2001","journal-title":"Ann Med Interne (Paris)"},{"issue":"12","key":"10.1016\/j.gtc.2020.01.008_bib77","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1086\/379711","article-title":"Cytomegalovirus infection in immunocompetent patients","volume":"37","author":"Wreghitt","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib78","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/121.6.608","article-title":"Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies","volume":"121","author":"Klemola","year":"1970","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib79","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jceh.2017.05.011","article-title":"Cytomegalovirus infection in liver transplant recipients: current approach to diagnosis and management","volume":"7","author":"Yadav","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"31","key":"10.1016\/j.gtc.2020.01.008_bib80","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.3748\/wjg.v20.i31.10658","article-title":"Cytomegalovirus infection in liver transplant recipients: updates on clinical management","volume":"20","author":"Marcelin","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"31","key":"10.1016\/j.gtc.2020.01.008_bib81","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3748\/wjg.14.4849","article-title":"Cytomegalovirus infection after liver transplantation: current concepts and challenges","volume":"14","author":"Razonable","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2020.01.008_bib82","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00595-012-0209-6","article-title":"Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case","volume":"43","author":"Yu","year":"2013","journal-title":"Surg Today"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib83","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-88-6-810","article-title":"Fatal massive hepatic necrosis in cytomegalovirus mononucleosis","volume":"88","author":"Shusterman","year":"1978","journal-title":"Ann Intern Med"},{"issue":"43","key":"10.1016\/j.gtc.2020.01.008_bib84","doi-asserted-by":"crossref","first-page":"12505","DOI":"10.3748\/wjg.v21.i43.12505","article-title":"Cholestasis, ascites and pancytopenia in an immunocompetent adult with severe cytomegalovirus hepatitis","volume":"21","author":"Qian","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2020.01.008_bib85","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00004836-199910000-00010","article-title":"Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir","volume":"29","author":"Serna-Higuera","year":"1999","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib86","first-page":"295","article-title":"Cytomegalovirus hepatitis and pancreatitis in the immunocompetent","volume":"14","author":"Chan","year":"2014","journal-title":"Ochsner J"},{"issue":"10","key":"10.1016\/j.gtc.2020.01.008_bib87","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00535-005-1683-z","article-title":"Cytomegalovirus cholangitis and pancreatitis in an immunocompetent patient","volume":"40","author":"Oku","year":"2005","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2020.01.008_bib88","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1086\/509641","article-title":"A\u00a0case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients","volume":"44","author":"Squizzato","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gtc.2020.01.008_bib89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-230X-6-10","article-title":"Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report","volume":"6","author":"Spahr","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2020.01.008_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinids\/24.1.52","article-title":"Severe cytomegalovirus infection in immunocompetent patients","volume":"24","author":"Eddleston","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.gtc.2020.01.008_bib91","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/jvh.13176","article-title":"Cytomegalovirus hepatitis after bone marrow transplantation: an autopsy study with clinical, histologic, and laboratory correlates","volume":"26","author":"McDonald","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"issue":"5","key":"10.1016\/j.gtc.2020.01.008_bib92","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/infdis\/160.5.752","article-title":"Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations","volume":"160","author":"Paya","year":"1989","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.gtc.2020.01.008_bib93","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1053\/jlts.2002.36732","article-title":"CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up","volume":"8","author":"Seehofer","year":"2002","journal-title":"Liver Transplant"},{"issue":"22","key":"10.1016\/j.gtc.2020.01.008_bib94","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2169\/internalmedicine.47.1480","article-title":"Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir","volume":"47","author":"Fernandez-Ruiz","year":"2008","journal-title":"Intern Med"},{"issue":"12","key":"10.1016\/j.gtc.2020.01.008_bib95","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/TP.0b013e3182708e56","article-title":"Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis","volume":"94","author":"Andrassy","year":"2012","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.gtc.2020.01.008_bib96","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ctr.12552","article-title":"The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation","volume":"29","author":"Sheng","year":"2015","journal-title":"Clin Transplant"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985532030008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985532030008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:30:09Z","timestamp":1760178609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985532030008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S088985532030008X"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2020.01.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr Virus and Cytomegalovirus Infections of the Liver","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2020.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}